Looming Patent Expiry of Blockbuster Drugs to Negatively Influence Demand for Hospital Pharmaceuticals Globally, Forecasts TMR Date: 02-24-2017 05:02 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Pharmaceutical
The looming patent expiry of blockbuster drugs and the need for maintaining the flow of novel therapeutics have led to realization that pharmaceutical companies cannot allow the status quo to remain as it is. Collaborating with other key players has thus become a popular strategy among leading enterprises vying to benefit from a stronger product pipeline. As per Transparency Market Research, Sanofi, Roche, Novartis, and Pfizer dominated the global hospital pharmaceuticals market in 2014, collectively holding a share of 18.6%. Among these companies, Novartis held the dominant share of 5.5% in the global market, followed by Pfizer that held 4.8% share in the global market. Browse Global Strategic Business Report: www.transparencymarketresearch.com/hospital-pharmaceutica... Developing Economies to Exhibit Lucrative Opportunities Developing economies are expected to report the most lucrative prospects for these companies. Lower pricing therefore could be of advantage for enterprises seeking to expand their operations. TMR recommends that focusing on value adding activities could reduce operational cost incurred by a pharmaceutical company and improve its process efficiency. The global hospital pharmaceuticals market is expected to gain significantly from the increasing emergency visits. As told by TMR’s lead analyst, “The rate of emergency department visits has outpaced growth reported by the hospital pharmaceuticals market in the last decade, which has significantly contributed in boosting sales of specialty drugs.” “The increasing spending on nominal drugs, combined with rising per capital healthcare expenditure, is expected to positively influence the market’s trajectory,” he added. Market to Gain Impetus from High Prevalence of Chronic Ailments Besides this, the high prevalence of chronic ailments worldwide is also likely to fuel demand from the global hospital
Seite 1 / 4
pharmaceuticals market. The increasing prevalence of these diseases is primarily contributed by the changing lifestyle, rising geriatric population, and excessive addition to tobacco and alcohol. Download Exclusive Brochure of This Report : www.transparencymarketresearch.com/sample/sample.php?flag... The market is also expected to significantly gain from the increasing trend of using telemedicine technology. However, the impending patent expiry of blockbuster drugs is likely to impact the market negatively. The rising trend of home healthcare will also negatively influence the market’s trajectory in the near future. Entry of generic drug producers also pose a threat to the companies operating in the global hospital pharmaceuticals market. Nevertheless, the extensive research and development activities undertaken by key players and research organizations are expected to boost prospects for the market in the near future. Opportunities for the market is also expected to bolster with the increasing construction of hospitals and the rising healthcare spending worldwide. North America to Emerge as Dominant Regional Market Regionally, the opportunities for the global hospital pharmaceuticals market seem the most lucrative in North America. As per TMR, the North America hospital pharmaceuticals market is expected to surge at a CAGR of 3.4% between 2015 and 2023. The region held a dominant share of 57.5% in the global market in 2014. Europe is likely to emerge as the second-largest market for hospital pharmaceuticals during the same forecast period. In the meantime, the increasing opportunities in Asia Pacific and Latin America will compel leading vendors to shift their focus from developed to developing economies. The large population base in Asia Pacific and the increasing investment on the healthcare sector will boost opportunities for the hospital pharmaceuticals market in the region. As per TMR, the global hospital pharmaceuticals market is expected to surge at a CAGR of 3.9% between 2015 and 2023. The market stood at US$197.3 bn in 2014 and is expected to reach US$280.3 bn by the end of 2023. This review is based on information published by Transparency Market Research in a report, titled “Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.” The report segments the market as: Cardiology Anti-hypertensives Dyslipidemia drugs Others Oncology Alkylating Agents Anti-metabolites Hormonal Agents Immunomodulating Agents Miscellaneous Drugs Nephrology and Urology Diuretic Agents Anti-hypertensive Agents Phosphate Binders Anticholinergic Drugs 5-Alpha Reductase Inhibitors Neurology Anti-anxiety Agents Anti-migraine Drugs Antidepressant Drugs Anti-psychotic Drugs
Seite 2 / 4
Pain Anticonvulsant Drugs Anesthetic Drugs Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Opioids Non-narcotics Analgesic Drugs Infection Antibacterial Drugs Antiviral Drugs Antifungal Drugs Antiparasite Drugs Global Hospital Pharmaceuticals Market, by Indication Cardiology Coronary Heart Diseases Stroke High Blood Pressure Heart Failure Others Oncology Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Nephrology and Urology Acute Kidney Failure Chronic Kidney Diseases Glomerular Diseases Diabetes Others Neurology Epilepsy Alzheimer’s Disease Parkinson’s Disease Multiple Sclerosis Others Pain Neuropathic Pain Fibromyalgia Osteoarthritis Rheumatoid Arthritis Cancer Pain Infection Tuberculosis Pneumonia Hepatitis A Hepatitis B Candida Infection Fungal Meningitis Shigellosis Amoebiasis Other Global Hospital Pharmaceuticals Market, by Geography
Seite 3 / 4
North America S. Canada Asia Pacific China Japan Rest of APAC Europe K. Germany Rest of Europe Latin America Brazil Mexico Rest of Latin America Rest of the World About Us Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement. US Office Contact 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: www.transparencymarketresearch.com You can find this press release here
Seite 4 / 4